Early stage IT and Healthcare Investing

BioMimetic

portfoliocompanies

company snapshot

Biomimetic

BioMimetic Therapeutics develops and commercializes clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for orthopedic and sports medicine applications. BioMimetic has become a leader in regenerative medicine by providing new treatment options for the repair of bone, cartilage, tendons and ligaments. BioMimetic was acquired by Wright Medical Group in 2013.

website
www.biomimetics.com
Leadership
Follow The Company
Investment Team
Samuel Lynch, President & CEO
Facebook Google+ Twitter Email LinkedIn Share